TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
HIMS

Hims Hers Health Inc

Healthcare · Drug Manufacturers - Specialty & Generic

29.30$ +3.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement HIMS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +209.4% +80.2% +82.8% +93.8% +65.5% +69.3% +59.0%
– +101.1% +3.6% +71.4% +75.4% +32.9% +93.2% +102.5%
– +471.6% +145.4% +86.8% +99.9% +74.9% +64.1% +47.8%
– – – +99.1% +30.6% +65.0% +63.4% +89.4%
– +99.5% -2.7% +109.1% -13.6% +32.3% +29.2% +62.6%
– +42.4% +4.7% +156.5% +49.4% +55.9% +49.3% +46.5%
– – – – – – – +70.6%
– – -97.3% +37,920.0% -21.4% – – –
– – – – – – – +72.8%
– +143.2% +41.1% -2,569.3% – – -2,850.7% –
– – – – – – – +1.8%
– – – – – – – +100.9%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?